Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
gemicitabine 1000mg/m2, day1 and day 8, every 3 week, 6
UFT 250mg/m2, daily for 1 year
Locations
1
Japan
Osaka City General Hospital
Osaka, Osaka, Japan
Start Date
December 1, 2001
Last Updated
January 6, 2006
NCT06066138
NCT05692635
NCT05198830
NCT06305754
NCT07336732
NCT07190248
Lead Sponsor
West Japan Thoracic Oncology Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions